News Focus
News Focus
Followers 0
Posts 2393
Boards Moderated 0
Alias Born 09/22/2012

Re: Shaka_Zulu post# 15295

Thursday, 07/17/2014 7:00:33 PM

Thursday, July 17, 2014 7:00:33 PM

Post# of 20777
Yeah why would they only delay a week if it were not one of the first two.I've said all along Pfizer wanted Intellect its pipeline platforms and patents.

They don't want just a license/contract they want everything.

250 to 500 million would be a steal.Pfizer with its unlimited funds could take this platform CONJUMAB and make a killing.I'm talking about 10's of billions.

http://ir.stockpr.com/intellectns/press-releases/detail/893/intellect-neurosciences-issues-letter-to-shareholders


In 2013 we plan to move forward aggressively with our CONJUMAB and tau immunotherapy programs. These activities are expected to generate data that will increase the enterprise value of each program and attract new partnership opportunities that could result in substantial license revenues. This strategy is based on recent discussions with global pharmaceutical companies, several of which have expressed high levels of interest in these preclinical programs.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today